The Effect of HealthWear on Short-Term Weight Loss
1 other identifier
interventional
75
1 country
1
Brief Summary
The purpose of this study is to examine the effect of a computer tracking system and energy expenditure device on weight loss in adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jun 2005
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedApril 3, 2023
September 1, 2005
September 13, 2005
March 29, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
weight loss
Secondary Outcomes (4)
fitness
physical activity
dietary intake
mediators
Interventions
Eligibility Criteria
You may qualify if:
- years of age.
- Body mass index (BMI) between 25.0-39.9 kg/m2.
- Access to a computer, Internet access, and will demonstrate proficiency with using the Internet and Web-based software programs. Potential participants will be asked to provide the type of computer they have, the name of their internet service provider, and will have to demonstrate their ability to search the internet during their screening visit.
You may not qualify if:
- Report losing \>5% of current body weight in the previous 6 months.
- Report participating in a research project involving weight loss or physical activity in the previous 6 months.
- For women, report being pregnant during the previous 6 months, or planning on becoming pregnant over the following 3 months of the intervention. (Pregnancy during initial screening will be based on self-report and will be included on the detailed medical history that is completed by subjects. In addition, this will also be obtained as part of the signed medical clearance from the individual's personal physician.)
- Currently being treated for any medical condition that could impact body weight (i.e., diabetes mellitus, cancer, etc.).
- History of myocardial infarction, or a history of undergoing heart surgery such as bypass or angioplasty.
- Taking medication that would affect heart rate or blood pressure responses to exercise (e.g., beta blockers).
- Taking medication that could affect metabolism and/or contribute to a change in body weight (e.g., synthroid).
- Being treated by a therapist for psychological issues or problems, taking pyschotropic medications, or receiving treatment with psychotropic medications within the previous 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- Roche Diagnostics GmbHcollaborator
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15203, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John M Jakicic, Ph.D.
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 15, 2005
Study Start
June 1, 2005
Study Completion
September 1, 2005
Last Updated
April 3, 2023
Record last verified: 2005-09